|
| Press Releases |
|
 |
|
| Wednesday, August 17, 2022 |
|
|
CNERGENZ Posts RM76.58 Million in Revenue for 2Q FY2022 |
| CNERGENZ Berhad, an established electronics manufacturing solutions provider based in Penang, announced today that the Company recorded revenue of RM76.58 million for the second quarter ended 30 June 2022 (2QFY2022) on higher sales of standalone surface mount technology (SMT) machines and provision of integrated solutions due to continued demand from manufacturing activities in the electronics and semiconductor industries (E&S Industries). more info >> |
|
| Friday, May 27, 2022 |
|
|
CNERGENZ Berhad Posts RM36.9 Million in Revenue for 1Q FY2022 |
| CNERGENZ Berhad (CNERGENZ), an established electronics manufacturing solutions provider based in Penang, has announced its financial results for the first quarter ended 31 March 2022 (1QFY2022) today. more info >> |
|
| Wednesday, May 25, 2022 |
|
|
CNERGENZ Berhad Lists on ACE Market, Share Price Gains 4.31% to RM0.605 on Debut |
| CNERGENZ Berhad (CNERGENZ), an established electronics manufacturing solutions provider based in Penang, has made its debut on the ACE Market of Bursa Malaysia Securities Berhad (Bursa Securities) under the Technology sector, opening at RM0.605 per share, which is a premium of RM0.025 or 4.31% above the IPO price of RM0.58 per share. more info >> |
|
| Friday, May 13, 2022 |
|
|
CNERGENZ Berhad IPO Shares Oversubscribed by 40.32 Times |
| CNERGENZ Berhad (CNERGENZ) is pleased to announce that the share allocation to the Malaysian public from its IPO has been oversubscribed by 40.32 times. more info >> |
|
| Friday, April 29, 2022 |
|
|
CNERGENZ Berhad launches Prospectus for ACE Market IPO |
| Cnergenz Berhad (CNERGENZ), an established electronics manufacturing solutions provider based in Penang, has launched the Company's Prospectus today for its upcoming initial public offering (IPO) on the ACE Market of Bursa Malaysia Securities Berhad (Bursa Securities). more info >> |
|
| Monday, April 4, 2022 |
|
|
Electronics Manufacturing Solutions Provider Cnergenz Berhad Enlists UOB Kay Hian Securities as Underwriter for Its Listing Exercise |
| CNERGENZ Berhad is pleased to announce that the Company has entered into an underwriting agreement with UOB Kay Hian Securities (M) Sdn. Bhd. ("UOB Kay Hian") today for its upcoming initial public offering ("IPO") on the ACE Market of Bursa Malaysia Securities Berhad ("Bursa Securities"). more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
International Women's Day: Why Menopause May Be a Missed Cardiovascular Risk Window
Mar 6, 2026 20:00 JST
|
|
|
Xunce (3317.HK) Released Profit Alert: Revenue Doubles, Surpasses Expectations by a Wide Margin, China's Palantir Rises!
Mar 6, 2026 18:23 HKT/SGT
|
|
|
迅策(3317.HK)發佈盈利預告：營收翻翻 大超預期 中國版Palantir崛起！
Mar 6, 2026 18:17 HKT/SGT
|
|
|
迅策(3317.HK)发布盈利预告：营收翻翻 大超预期 中国版Palantir崛起！
Mar 6, 2026 18:00 HKT/SGT
|
|
|
香港實現綠色甲醇首船加注 推動國際航運中心綠色轉型
Mar 6, 2026 15:40 HKT/SGT
|
|
|
香港实现绿色甲醇首船加注 推动国际航运中心绿色转型
Mar 6, 2026 15:31 HKT/SGT
|
|
|
Hong Kong Completes First Green Methanol Bunkering, Driving Green Transformation of Its International Shipping Hub
Mar 6, 2026 15:05 HKT/SGT
|
|
|
Hong Kong Tech Innovators Drive Success at Mobile World Congress and 4YFN Barcelona 2026
Mar 6, 2026 13:08 HKT/SGT
|
|
|
U.S. Polo Assn. Expands Collegiate Partnership Program to Record 70 Teams for 2026 Season
Mar 6, 2026 12:12 HKT/SGT
|
|
|
Anime Tokyo Station: "That Time I Got Reincarnated as a Slime" Special Exhibition, February 21 to May 24, 2026
Mar 6, 2026 10:00 HKT/SGT
|
|
|
TANAKA Develops World's First High-Performance Palladium Hydrogen Permeable Membrane Exhibiting High Hydrogen Purification Performance at Temperatures around 100 degrees C
Mar 5, 2026 22:00 JST
|
|
|
美國馬球協會擴大大學合作計畫 2026賽季隊伍數創紀錄達70支
Mar 5, 2026 20:00 HKT/SGT
|
|
|
美国马球协会扩大大学合作计划，2026赛季参赛队伍创纪录达70支
Mar 5, 2026 20:00 HKT/SGT
|
|
|
Lancaster Resources Announces Resignation of Penny White and the Addition of Rob Heaslop to the Board of Directors
Mar 5, 2026 17:29 HKT/SGT
|
|
|
CMS (867.HK/8A8.SG): Self-Developed INHBE-Targeting siRNA Drug Received IND Approval for Overweight/Obesity
Mar 5, 2026 17:00: JST
|
|
|
|
|
More News >> |
|
|
|
|
|
